A Study of Lanadelumab (Takhzyro) and Icatibant (Firazyr ®) in Persons With HAE in China

Conditions: Hereditary Angioedema (HAE) Interventions: Other: No intervention Sponsors: Takeda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: China Health | Research | Study